83 related articles for article (PubMed ID: 11866899)
1. [The expression and clinical significance of p80 protein in anaplastic large cell lymphoma].
Li J; Li G; Liu W; Li F
Zhonghua Bing Li Xue Za Zhi; 2000 Apr; 29(2):99-102. PubMed ID: 11866899
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80(NPM/ALK) expression.
Nakamura S; Shiota M; Nakagawa A; Yatabe Y; Kojima M; Motoori T; Suzuki R; Kagami Y; Ogura M; Morishima Y; Mizoguchi Y; Okamoto M; Seto M; Koshikawa T; Mori S; Suchi T
Am J Surg Pathol; 1997 Dec; 21(12):1420-32. PubMed ID: 9414185
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
[TBL] [Abstract][Full Text] [Related]
4. The clinicopathological features of anaplastic large cell lymphomas expressing p80NPM/ALK.
Shiota M; Mori S
Leuk Lymphoma; 1996 Sep; 23(1-2):25-32. PubMed ID: 9021682
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of p80 and visceral involvement in childhood CD30 anaplastic large cell lymphoma (ALCL).
Massimino M; Spreafico F; Luksch R; Giardini R
Med Pediatr Oncol; 2001 Aug; 37(2):97-102. PubMed ID: 11496346
[TBL] [Abstract][Full Text] [Related]
6. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders.
Su LD; Schnitzer B; Ross CW; Vasef M; Mori S; Shiota M; Mason DY; Pulford K; Headington JT; Singleton TP
J Cutan Pathol; 1997 Nov; 24(10):597-603. PubMed ID: 9449486
[TBL] [Abstract][Full Text] [Related]
7. Expression of carbohydrate antigens, p80NPM/ALK, cytotoxic cell-associated antigens, and Epstein-Barr virus gene products in anaplastic large cell lymphomas.
Kasai K; Kon S; Kikuchi K; Sato Y; Kameya T
Pathol Int; 1998 Mar; 48(3):171-8. PubMed ID: 9589484
[TBL] [Abstract][Full Text] [Related]
8. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features.
Felgar RE; Salhany KE; Macon WR; Pietra GG; Kinney MC
Hum Pathol; 1999 Feb; 30(2):228-36. PubMed ID: 10029454
[TBL] [Abstract][Full Text] [Related]
9. CD30 and the NPM-ALK fusion protein (p80) are differentially expressed between peripheral blood and bone marrow in primary small cell variant of anaplastic large cell lymphoma.
Awaya N; Mori S; Takeuchi H; Mori S; Sugano Y; Kamata T; Takeuchi T; Abe T
Am J Hematol; 2002 Mar; 69(3):200-4. PubMed ID: 11891807
[TBL] [Abstract][Full Text] [Related]
10. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
[TBL] [Abstract][Full Text] [Related]
11. Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood.
Hutchison RE; Banki K; Shuster JJ; Barrett D; Dieck C; Berard CW; Murphy SB; Link MP; Pick TE; Laver J; Schwenn M; Mathew P; Morris SW
Ann Oncol; 1997; 8 Suppl 1():37-42. PubMed ID: 9187427
[TBL] [Abstract][Full Text] [Related]
12. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Nakamura S; Ichinohasama R; Abe M; Akagi T; Takeshita M; Mori N; Fujimoto J; Miyauchi J; Mikata A; Nanba K; Takami T; Yamabe H; Takano Y; Izumo T; Nagatani T; Mohri N; Nasu K; Satoh H; Katano H; Fujimoto J; Yamamoto T; Mori S
Blood; 1995 Sep; 86(5):1954-60. PubMed ID: 7655022
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity.
Shiota M; Mori S
Leukemia; 1997 Apr; 11 Suppl 3():538-40. PubMed ID: 9209450
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA; Khan D; Hall GW; Collins GP
Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
[TBL] [Abstract][Full Text] [Related]
16. CD30-positive anaplastic large cell lymphoma in childhood: expression of p80npm/alk and absence of Epstein-Barr virus.
Nakagawa A; Nakamura S; Ito M; Shiota M; Mori S; Suchi T
Mod Pathol; 1997 Mar; 10(3):210-5. PubMed ID: 9071728
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of the NPM-ALK fusion gene in bone marrow and peripheral blood for patients with anaplastic large cell lymphoma].
Yang J; Zhao XX; Jin L; Duan YL; Huang S; Zhang M; Zhang R; Zhou CJ; Zhang YH
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):700-3. PubMed ID: 23978023
[TBL] [Abstract][Full Text] [Related]
18. [Expression of anaplastic lymphoma kinase and survivin proteins in anaplastic large cell lymphoma and its significance].
Li JF; Li GD; Liu WP; Wang Y; Cheng JR; Chen Y; Yang H; Tang HL; Bai YQ; Lin DG; DU LH; Peng FX; Yang YH; Zhao C
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):213-7. PubMed ID: 16776978
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
Jaffe ES
Mod Pathol; 2001 Mar; 14(3):219-28. PubMed ID: 11266530
[TBL] [Abstract][Full Text] [Related]
20. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum.
Falini B; Bigerna B; Fizzotti M; Pulford K; Pileri SA; Delsol G; Carbone A; Paulli M; Magrini U; Menestrina F; Giardini R; Pilotti S; Mezzelani A; Ugolini B; Billi M; Pucciarini A; Pacini R; Pelicci PG; Flenghi L
Am J Pathol; 1998 Sep; 153(3):875-86. PubMed ID: 9736036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]